Nataša Stojanović
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nataša Stojanović has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Marta Zuvic-Butorac
University of Rijeka, Croatia
1 shared publication - Miro Šimun Alebić
Podobnik Maternity & Gynecology Hospital, 10000 Zagreb, Croatia
1 shared publication - Miro Šimun Alebić
Department of Human Reproduction, Merkur Teaching Hospital, 10 000 Zagreb, Croatia
1 shared publication
Latest Publications
- 1 February 2014
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 28 (2) , 191-197
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration
- 1 February 2014
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 28 (2) , 191-197
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration
- Open Access
- 24 February 2013
- Published by Wiley in International Journal of Endocrinology
- Vol. 2013, 1-7
The IVF Outcome Counseling Based on the Model Combining DHEAS and Age in Patients with Low AMH Prior to the First Cycle of GnRH Antagonist Protocol of Ovarian Stimulation
Objective. To investigate the endocrine and/or clinical characteristics of women with low anti-Müllerian hormone (AMH) that could improve the accuracy of IVF outcome prediction based on the female age alone prior to the first GnRH antagonist IVF cycle.Methods. Medical records of 129 patients with low AMH level (Results. Clinical pregnancy rate (CPR) per initiated cycles was 11.6%. For the prediction of clinical pregnancy, DHEAS and age showed AUC-ROC of 0.726 (95%CI 0.641–0.801) and 0.662 (95%CI 0.573–0.743), respectively (). The predictive accuracy of the model combining age and DHEAS (AUC-ROC 0.796; 95%CI 0.716–0.862) was significantly higher compared to that of age alone (). In patients Conclusions. DHEAS appears to be predictive for clinical pregnancy in younger women (<37.5 years) with low AMH after the first GnRH antagonist IVF cycle. Therefore, DHEAS-age model could refine the pretreatment counseling on pregnancy prospects following IVF.
- 24 February 2013
- Published by Wiley in International Journal of Endocrinology
- Vol. 2013, 1-7
Open AccessThe IVF Outcome Counseling Based on the Model Combining DHEAS and Age in Patients with Low AMH Prior to the First Cycle of GnRH Antagonist Protocol of Ovarian Stimulation
Objective. To investigate the endocrine and/or clinical characteristics of women with low anti-Müllerian hormone (AMH) that could improve the accuracy of IVF outcome prediction based on the female age alone prior to the first GnRH antagonist IVF cycle.Methods. Medical records of 129 patients with low AMH level (Results. Clinical pregnancy rate (CPR) per initiated cycles was 11.6%. For the prediction of clinical pregnancy, DHEAS and age showed AUC-ROC of 0.726 (95%CI 0.641–0.801) and 0.662 (95%CI 0.573–0.743), respectively (). The predictive accuracy of the model combining age and DHEAS (AUC-ROC 0.796; 95%CI 0.716–0.862) was significantly higher compared to that of age alone (). In patients Conclusions. DHEAS appears to be predictive for clinical pregnancy in younger women (<37.5 years) with low AMH after the first GnRH antagonist IVF cycle. Therefore, DHEAS-age model could refine the pretreatment counseling on pregnancy prospects following IVF.